SCHEMBL6510427

SCHEMBL6510427

NC(=O)c1ccccc1Cc1cc[nH]n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
KDM4E B2RXH2 3/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CSNK1A1 P48729 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 2/20 0.37
PARP1 P09874 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
METAP2 P50579 1/20 0.36
CTNNB1 P35222 1/20 0.36
BCAT2 O15382 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
PDPK1 O15530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30623519 0.80 PARP1 (0.34) MAPTMEN1KMT2APARP1PDPK1
SCHEMBL7160194 0.78 MAPT (0.38) MAPTKDM4ETSHRALDH1A1HPGD
SCHEMBL7134588 0.77 TSHR (0.54) MAPTKDM4ETSHRALDH1A1HPGD
SCHEMBL10917979 0.75 HSPA5 (0.54) TSHR
SCHEMBL16619753 0.75 GPR84 (0.42) ALDH1A1PARP1
SCHEMBL166483 0.74 PARP10 (0.48) KDM4ETSHRALDH1A1HPGDHSD17B10
SCHEMBL29818128 0.74 PARP10 (0.48) KDM4ETSHRALDH1A1HPGDHSD17B10
SCHEMBL4759339 0.74 PARP1 (0.39) MAPTKDM4ETSHRALDH1A1HPGD
SCHEMBL7161351 0.74 NPC1 (0.50) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL30839547 0.72 KDM4E (0.38) MAPTKDM4ETSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019182-A1 PYRAZOLYLMETHYLBENZAMIDE DERIVATIVES AS P2XT-RECEPTOR ANTAGONISTS BAYER HEALTHCARE AG (DE) 2005-03-03 WO claimed
WO-2005019182-A1 PYRAZOLYLMETHYLBENZAMIDE DERIVATIVES AS P2XT-RECEPTOR ANTAGONISTS BAYER HEALTHCARE AG (DE) 2005-03-03 WO disclosed
WO-2005019182-A1 PYRAZOLYLMETHYLBENZAMIDE DERIVATIVES AS P2XT-RECEPTOR ANTAGONISTS BAYER HEALTHCARE AG (DE) 2005-03-03 WO disclosed